financetom
Business
financetom
/
Business
/
Resmed Insider Sold Shares Worth $439,480, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Resmed Insider Sold Shares Worth $439,480, According to a Recent SEC Filing
Apr 4, 2025 10:10 AM

12:53 PM EDT, 04/04/2025 (MT Newswires) -- Peter C Farrell, Director, on April 02, 2025, sold 2,000 shares in Resmed ( RMD ) for $439,480. Following the Form 4 filing with the SEC, Farrell has control over a total of 73,218 common shares of the company, with 73,218 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/943819/000112760225011625/xslF345X05/form4.xml

Price: 207.16, Change: -6.19, Percent Change: -2.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Home BancShares Q3 Adjusted Earnings, Revenue Increase
Home BancShares Q3 Adjusted Earnings, Revenue Increase
Oct 15, 2025
05:32 PM EDT, 10/15/2025 (MT Newswires) -- Home BancShares ( HOMB ) reported Q3 adjusted earnings late Wednesday of $0.61 per diluted share, up from $0.50 a year earlier. Analysts polled by FactSet expected $0.60 per share. Revenue for the quarter ended Sept. 30 was $277.7 million, up from $258 million a year earlier. Analysts surveyed by FactSet expected $270...
Pinnacle Financial Partners Q3 revenue up 16.7% on loan growth
Pinnacle Financial Partners Q3 revenue up 16.7% on loan growth
Oct 15, 2025
Overview * Pinnacle Q3 revenue increased 16.7% yr/yr, driven by loan growth * Adjusted EPS for Q3 increased 22% yr/yr, reflecting improved operational performance * Pinnacle progresses on Synovus merger, expects regulatory approvals by early 2026 Outlook * Pinnacle expects continued expansion of net interest margin in Q4 2025 * Company anticipates Federal funds rate decreases in Q4 2025 *...
Kymera Therapeutics Insider Sold Shares Worth $3,659,254, According to a Recent SEC Filing
Kymera Therapeutics Insider Sold Shares Worth $3,659,254, According to a Recent SEC Filing
Oct 15, 2025
05:33 PM EDT, 10/15/2025 (MT Newswires) -- Jared Gollob, Chief Medical Officer, on October 15, 2025, sold 59,576 shares in Kymera Therapeutics ( KYMR ) for $3,659,254. Following the Form 4 filing with the SEC, Gollob has control over a total of 109,992 common shares of the company, with 109,992 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1815442/000119312525240430/xslF345X05/ownership.xml ...
Cytek Biosciences Relocates European Headquarters to New Facility in Amsterdam
Cytek Biosciences Relocates European Headquarters to New Facility in Amsterdam
Oct 15, 2025
05:30 PM EDT, 10/15/2025 (MT Newswires) -- Cytek Biosciences ( CTKB ) said late Wednesday it relocated its European headquarters to a new facility in Amsterdam's Life Sciences District to drive growth and improve services for clients. The new site accommodates Cytek's European offices and a warehouse, along with a dedicated customer service and training center, the company said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved